These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Prevention of primary nonfunction of xenograft islets. Pittman K, Henretta J, McFadden T, Thomas J, Thomas FT. Transplant Proc; 1994 Jun; 26(3):1141-2. PubMed ID: 8029862 [No Abstract] [Full Text] [Related]
4. Long-term (10-month) pig islet xenograft tolerance using measured total lymphoid irradiation, splenectomy, short-term rabbit antithymocyte globulin, and deoxyspergualin without long-term immunosuppression. Llyung T, Contreras J, Thomas F, Pittman K, Thomas J. Transplant Proc; 1999 Jun; 31(1-2):962-3. PubMed ID: 10083428 [No Abstract] [Full Text] [Related]
5. Reduction of primary nonfunction in discordant pancreas islet xenografts. Pittman K, Thomas J, Thomas F. Transplant Proc; 1992 Apr; 24(2):649-50. PubMed ID: 1566465 [No Abstract] [Full Text] [Related]
6. Survival of human islet xenografts irradiated with ultraviolet B in diabetic rats. Sung RS, Fiedor PS, Yaron I, Zakheim AR, Quadracci KM, Goodman ER, Hardy MA. Transplant Proc; 1996 Apr; 28(2):839. PubMed ID: 8623427 [No Abstract] [Full Text] [Related]
7. Local immunologic factors determine the occurrence of primary nonfunction of islet xenografts. Marquet RL, Bouwman E, Bonthuis F, Wolvekamp MC, Kouwenhoven E, van Rooijen N, Scheringa M, Ijzermans JN. Transplant Proc; 1994 Apr; 26(2):766-7. PubMed ID: 8171654 [No Abstract] [Full Text] [Related]
8. Deoxyspergualin is a unique immunosuppressive agent with selective utility in inducing tolerance to pancreas islet xenografts. Thomas F, Pittman K, Ljung T, Cekada E. Transplant Proc; 1995 Feb; 27(1):417-9. PubMed ID: 7879045 [Abstract] [Full Text] [Related]
13. Pig-to-human islet transplantation in eight patients. Tibell A, Groth CG, Möller E, Korsgren O, Andersson A, Hellerström C. Transplant Proc; 1994 Apr; 26(2):762-3. PubMed ID: 8171652 [No Abstract] [Full Text] [Related]
14. In vivo function of pig islet xenografts in immunosuppressed diabetic mice. Tai J, Cheung SS, Tsang A, Tze WJ. Transplant Proc; 1995 Dec; 27(6):3316-7. PubMed ID: 8539968 [No Abstract] [Full Text] [Related]
16. Long-term culture or complement inhibition improves early islet function in dog to rat islet xenotransplantation. Deng S, Ketchum RJ, Levy MM, Perloff JR, White DJ, Naji A, Brayman KL. Transplant Proc; 1996 Apr; 28(2):805-6. PubMed ID: 8623408 [No Abstract] [Full Text] [Related]
17. Successful long-term pancreatic islet cell xenotransplantation and functional tolerance in NOD mice. Ljung T, Pittman K, Thomas FT. Transplant Proc; 1995 Feb; 27(1):1351-2. PubMed ID: 7878908 [Abstract] [Full Text] [Related]
18. Corticotropin-releasing hormone facilitates early survival of discordant (bovine-to-rat) islet xenografts. Lupi R, Marchetti P, Coppelli A, Giannarelli R, Petraglia F, Luisi S, Del Guerra S, Tellini C, Florio P, Genazzani A, Viacava P, Navalesi R. Transplant Proc; 1998 Aug; 30(5):2481-3. PubMed ID: 9723547 [No Abstract] [Full Text] [Related]
19. Effect of different temporary immunosuppressive therapies and low-temperature culture on pancreatic islet xenograft survival (pig-to-mouse). Marchetti P, Scharp DW, Finke E, Swanson CJ, Gerasimidi-Vazeou A, Olack BJ, Navalesi R, Lacy PE. Transplant Proc; 1994 Apr; 26(2):760-1. PubMed ID: 8171651 [No Abstract] [Full Text] [Related]
20. Islet xenografts in mice and rats: I. Exocrine tissue is detrimental to engraftment and survival of human islet xenografts. Nicolae M, Ketchum RJ, Jahr H, Janoff H, Brayman KL. Transplant Proc; 1994 Apr; 26(2):774. PubMed ID: 8171657 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]